Table of Contents
CsA Elimination Studies
Design of Studies Based on Standards of Elimination Trials
Randomized Withdrawal Trials: Similar Study Designs
One Phase III and One Phase II Trial in Renal Transplant Recipients
Primary Endpoints
Major Secondary Endpoints
Criteria for Exclusion from Randomization
Studies 310 and 212 Included 771 Patients
Study 310 Design and Dosing Regimen
Study 212 Dosing Regimen
Data Presentation
|
Author: Maureen Galie
|